Key words: clenbuterol/IGFs/masseter muscle/competitive RT-PCR/mouse mouse masseter muscle by altering the expressions of insulin-like growth factors (IGFs), their receptors (IGFRs), and their binding proteins (IGFBPs), we analyzed changes in the myofiber diameter, the expressions of myosin heavy chain (MHC) mRNAs, the markers for muscle fiber type, and the expressions of IGF, IGFR, and IGFBP mRNAs. In addition, to identify a possible contribution of muscle satellite cells in the change of the mouse masseter induced by clenbuterol, we analyzed the expressions of the myoD family (myf5, myoD, myogenin, and MRF4) and myocyte nuclear factor (MNF) mRNAs, and performed immunolocalization for proliferating cell nuclear antigen (PCNA), because they are all markers for via their drinking water for 2 weeks. The relative amounts of mRNAs were analyzed by competitive polymerase chain reaction in combination with reverse-transcription. The administration of clenbuterol increased the myofiber diameter by 26% (p<0.001), but it did not significantly change the amounts of MHC mRNAs, suggesting that clenbuterol induced hypertrophy but did not alter the fiber type. The administration of clenbuterol increased the amount of mRNA for IGF-I by 219% (p<0.05), but it decreased that for IGFBP3 by 21% (p<0.001).
Materials and Methods
Experimental animals
Twelve male ICR mice were purchased after weaning from Nippon Clea Inc. (Tokyo, Japan) and fed a hard diet (CE-2, Nippon Clea Inc., Tokyo, Japan).
They were divided into control and clenbuterol groups of 6 mice each at 6 months of age. We orally adminis- gene. The standard curve was generated as described previously25,27). Then, the quantity of endogenous S16 mRNA was quantified to normalize that of the target mRNA relative to the quantity of S16 mRNA, as described previously26). The resulting ratio value was To determine whether clenbuterol affects the body weight of mice and the mass of mouse muscle, we measured the body weight (Fig. 1) , the minimal diameters of the myofibers (Fig. 2 C) , and the weight of the masseter muscles (Fig. 2 D) . The body weights of all animals in both the control and clenbuterol groups were constant during the experimental period, showing no significant difference between the two groups ( Fig. 1) . The fibers, the cross-section of which is oblong or as oblong as possible, were selected and the minimal distance between the parallel sides of the oblong section was measured as the minimal diameter of the myofiber (white arrows in Figs. 2 A and 2 B) .
The minimal diameter in the clenbuterol group was indicate that a 2-week treatment with clenbuterol could induce hypertrophy of the mouse masseter muscle.
2. Clenbuterol did not alter the fiber type of the mouse masseter muscle To evaluate the effect of clenbuterol on the fiber type of the masseter muscle, we analyzed the expressions of myosin heavy chain (MHC) mRNAs as fiber type markers (Fig. 3) . No significant differences in the amounts of all MHC mRNAs studied were found between the clenbuterol and control groups. This indicates that clenbuterol did not alter the fiber type of the muscle. measured the relative amounts of mRNAs for IGFBP3 (Fig. 5 A) , 4 (Fig. 5 B) , 5 ( Fig. 5 C) , and 6 (Fig. 5 D (Fig. 6 ). Myf5 mRNA was not detectable by the PCR method. The clenbuterol did not induce a significant difference in the amounts of mRNAs for myoD (Fig. 6 A) , myogenin (Fig. 6 B) , MRF4 (Fig. 6 C) , and MNF (Fig. 6 D) . PCNA-positive cell nuclei were barely observed in both the control (Fig . 6 E) and clenbuterol ( Fig. 6 F) groups.
Discussion
In the present study, we observed that the oral administration of clenbuterol for 2 weeks induced hypertrophy of the mouse masseter muscle ( study, we found no significant differences in the relative amounts of mRNAs for the myoD family and MNF, and in immunolocalization for PCNA (Fig. 6 (Fig . 4 B) , the signal of elevate the production of IGF-I . In skeletal muscle tissues, it is reported that clenbuterol increases protein synthesis and/or decreases protein degradation1,2) , and that IGF-I regulates total protein metabo - In the present study, we found no significant differences in the relative amounts of mRNAs for all MHCs studied between the control and clenbuterol groups (Fig. 3) In the present study, we found no clenbuterol-induced changes in the relative amounts of mRNAs for IGF-II (Fig. 4 C) , and IGFBP4 (Fig. 5 B) and 5
( Fig. 5 C) in the mouse masseter muscle. However, previous reports have shown that clenbuterol administration increases the expression levels of mRNAs for these genes in association with the hypertrophy of rat plantaris and soleus muscles14,15), which is inconsistent with the present findings in the mouse masseter muscle. This inconsistency could be partially explained by differences in experimental conditions, such as the animal species, age, muscle type, and the duration and dose of clenbuterol administration. 
